Literature DB >> 27079292

Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains.

R Szabo1, A L Samson2, D A Lawrence3, R L Medcalf2, T H Bugge1.   

Abstract

UNLABELLED: Essentials C57BL/6J-tissue plasminogen activator (tPA)-deficient mice are widely used to study tPA function. Congenic C57BL/6J-tPA-deficient mice harbor large 129-derived chromosomal segments. The 129-derived chromosomal segments contain gene mutations that may confound data interpretation. Passenger mutation-free isogenic tPA-deficient mice were generated for study of tPA function.
SUMMARY: Background The ability to generate defined null mutations in mice revolutionized the analysis of gene function in mammals. However, gene-deficient mice generated by using 129-derived embryonic stem cells may carry large segments of 129 DNA, even when extensively backcrossed to reference strains, such as C57BL/6J, and this may confound interpretation of experiments performed in these mice. Tissue plasminogen activator (tPA), encoded by the PLAT gene, is a fibrinolytic serine protease that is widely expressed in the brain. A number of neurological abnormalities have been reported in tPA-deficient mice. Objectives To study genetic contamination of tPA-deficient mice. Materials and methods Whole genome expression array analysis, RNAseq expression profiling, low- and high-density single nucleotide polymorphism (SNP) analysis, bioinformatics and genome editing were used to analyze gene expression in tPA-deficient mouse brains. Results and conclusions Genes differentially expressed in the brain of Plat(-/-) mice from two independent colonies highly backcrossed onto the C57BL/6J strain clustered near Plat on chromosome 8. SNP analysis attributed this anomaly to about 20 Mbp of DNA flanking Plat being of 129 origin in both strains. Bioinformatic analysis of these 129-derived chromosomal segments identified a significant number of mutations in genes co-segregating with the targeted Plat allele, including several potential null mutations. Using zinc finger nuclease technology, we generated novel 'passenger mutation'-free isogenic C57BL/6J-Plat(-/-) and FVB/NJ-Plat(-/-) mouse strains by introducing an 11 bp deletion into the exon encoding the signal peptide. These novel mouse strains will be a useful community resource for further exploration of tPA function in physiological and pathological processes.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  brain; congenic mice; gene targeting; mutation; tissue plasminogen activator

Mesh:

Substances:

Year:  2016        PMID: 27079292      PMCID: PMC5322813          DOI: 10.1111/jth.13338

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  47 in total

1.  Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.

Authors:  Manel G Medina; Maria Dolores Ledesma; Jorge E Domínguez; Miguel Medina; Delia Zafra; Francesc Alameda; Carlos G Dotti; Pilar Navarro
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

2.  Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.

Authors:  Y F Wang; S E Tsirka; S Strickland; P E Stieg; S G Soriano; S A Lipton
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

3.  Plasminogen activator in the rodent brain.

Authors:  H Soreq; R Miskin
Journal:  Brain Res       Date:  1981-07-20       Impact factor: 3.252

4.  Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.

Authors:  Jed E Rose; Frédérique M Behm; Tomas Drgon; Catherine Johnson; George R Uhl
Journal:  Mol Med       Date:  2010-03-17       Impact factor: 6.354

5.  Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.

Authors:  Jennifer Barrow; Martyna Adamowicz-Brice; Maria Cartmill; Donald MacArthur; James Lowe; Keith Robson; Marie-Anne Brundler; David A Walker; Beth Coyle; Richard Grundy
Journal:  Neuro Oncol       Date:  2010-12-07       Impact factor: 12.300

6.  Tissue plasminogen activator is required for the development of fetal alcohol syndrome in mice.

Authors:  Melissa Noel; Erin H Norris; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

7.  Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice.

Authors:  Tom Vanden Berghe; Paco Hulpiau; Liesbet Martens; Roosmarijn E Vandenbroucke; Elien Van Wonterghem; Seth W Perry; Inge Bruggeman; Tatyana Divert; Sze Men Choi; Marnik Vuylsteke; Valery I Shestopalov; Claude Libert; Peter Vandenabeele
Journal:  Immunity       Date:  2015-07-07       Impact factor: 31.745

8.  Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.

Authors:  T H Bugge; M J Flick; C C Daugherty; J L Degen
Journal:  Genes Dev       Date:  1995-04-01       Impact factor: 11.361

Review 9.  Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer.

Authors:  R Tabarés-Seisdedos; J L R Rubenstein
Journal:  Mol Psychiatry       Date:  2009-02-10       Impact factor: 15.992

10.  Physiological consequences of loss of plasminogen activator gene function in mice.

Authors:  P Carmeliet; L Schoonjans; L Kieckens; B Ream; J Degen; R Bronson; R De Vos; J J van den Oord; D Collen; R C Mulligan
Journal:  Nature       Date:  1994-03-31       Impact factor: 49.962

View more
  5 in total

1.  PKCδ-positive GABAergic neurons in the central amygdala exhibit tissue-type plasminogen activator: role in the control of anxiety.

Authors:  Véronique Agin; Denis Vivien; Sara Douceau; Eloïse Lemarchand; Yannick Hommet; Laurent Lebouvier; Charlène Joséphine; Alexis-Pierre Bemelmans; Eric Maubert
Journal:  Mol Psychiatry       Date:  2022-02-10       Impact factor: 13.437

2.  Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke.

Authors:  Daniel Torrente; Enming Joseph Su; Linda Fredriksson; Mark Warnock; David Bushart; Kris M Mann; Cory D Emal; Daniel A Lawrence
Journal:  Transl Stroke Res       Date:  2022-02-04       Impact factor: 6.800

Review 3.  tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.

Authors:  Linda Fredriksson; Daniel A Lawrence; Robert L Medcalf
Journal:  Semin Thromb Hemost       Date:  2016-09-27       Impact factor: 4.180

4.  Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling.

Authors:  Mario Nuvolone; Marta Paolucci; Silvia Sorce; Veronika Kana; Rita Moos; Takashi Matozaki; Adriano Aguzzi
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

5.  Physiological and metabolic features of mice with CRISPR/Cas9-mediated loss-of-function in growth hormone-releasing hormone.

Authors:  Mert Icyuz; Michael Fitch; Fang Zhang; Anil Challa; Liou Y Sun
Journal:  Aging (Albany NY)       Date:  2020-05-18       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.